ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

SILO vs HCWB // EV/EBITDA & P/E VALUATION

Silo Pharma Inc. (NASDAQ) VS. HCW Biologics Inc. (NASDAQ) • 15-METRIC TALLY: SILO 3 — HCWB 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SILO VS. HCWB) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC SILO HCWB SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 38.60% 20.00% +18.60 SILO /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) 0.00% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 1/9 +2.00 SILO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 34.1 31.3 +2.84 SILO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $2.4M $2.6M -$259.8K HCWB /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR SILO REV HCWB REV SILO GROSS % HCWB GROSS % SILO FCF HCWB FCF
FY 2025 $72.1K $54.2K 38.6% 20.0% -$4.7M -$13.4M
FY 2024 $72.1K $2.6M 91.9% 37.4% -$3.8M -$14.5M
FY 2023 $72.1K $0 — — -$3.2M -$22.5M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SILO // BETA —
HCWB // BETA —